OtherPublishAheadOfPrint
Assessment of an 18F-Labeled Phosphoramidate Peptidomimetic as a New Prostate-Specific Membrane Antigen–Targeted Imaging Agent for Prostate Cancer
Suzanne E. Lapi, Hilla Wahnishe, David Pham, Lisa Y. Wu, Jessie R. Nedrow-Byers, Tiancheng Liu, Kaveh Vejdani, Henry F. VanBrocklin, Clifford E. Berkman and Ella F. Jones
Journal of Nuclear Medicine November 2009, DOI: https://doi.org/10.2967/jnumed.109.066589
Suzanne E. Lapi
Hilla Wahnishe
David Pham
Lisa Y. Wu
Jessie R. Nedrow-Byers
Tiancheng Liu
Kaveh Vejdani
Henry F. VanBrocklin
Clifford E. Berkman
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 3
March 1, 2024
Assessment of an 18F-Labeled Phosphoramidate Peptidomimetic as a New Prostate-Specific Membrane Antigen–Targeted Imaging Agent for Prostate Cancer
Suzanne E. Lapi, Hilla Wahnishe, David Pham, Lisa Y. Wu, Jessie R. Nedrow-Byers, Tiancheng Liu, Kaveh Vejdani, Henry F. VanBrocklin, Clifford E. Berkman, Ella F. Jones
Journal of Nuclear Medicine Nov 2009, DOI: 10.2967/jnumed.109.066589
Assessment of an 18F-Labeled Phosphoramidate Peptidomimetic as a New Prostate-Specific Membrane Antigen–Targeted Imaging Agent for Prostate Cancer
Suzanne E. Lapi, Hilla Wahnishe, David Pham, Lisa Y. Wu, Jessie R. Nedrow-Byers, Tiancheng Liu, Kaveh Vejdani, Henry F. VanBrocklin, Clifford E. Berkman, Ella F. Jones
Journal of Nuclear Medicine Nov 2009, DOI: 10.2967/jnumed.109.066589
Jump to section
Related Articles
Cited By...
- PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments
- 2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer